Rankings
▼
Calendar
RLAY FY 2018 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
RLAY
Relay Therapeutics, Inc.
$2B
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$2M
Operating Income
-$50M
Net Income
-$49M
EPS (Diluted)
$-19.63
Cash Flow
Operating Cash Flow
-$44M
Free Cash Flow
-$46M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$429M
Total Liabilities
$540M
Stockholders' Equity
-$111M
Cash & Equivalents
$422M
← Q1 2019
All Quarters